JP2012512151A5

JP2012512151A5 -

Download PDF

Info

Publication number: JP2012512151A5
Authority: JP; Japan
Prior art keywords: imidazo; vinyl; thiazole; carboxamide; thiazol
Prior art date: 2009-12-15
Legal status : Pending

Application number

JP2011540235A

Other languages

English (en)

Japanese (ja)

Other versions

JP2012512151A (ja

Filing date

2009-12-15

Publication date

2013-02-14

2009-12-15 Application filed filed Critical

2009-12-15 Priority claimed from PCT/IB2009/007951 external-priority patent/WO2010070452A1/en

2012-05-31 Publication of JP2012512151A publication Critical patent/JP2012512151A/ja

2013-02-14 Publication of JP2012512151A5 publication Critical patent/JP2012512151A5/ja

Status Pending legal-status Critical Current

Links

150000001875 compounds Chemical class 0.000 claims description 171
-1 6-{(E) -2- [2- (cyclopropylmethoxy) -3-methoxyphenyl] ethenyl} imidazo [2,1-b] [1,3] thiazol-5-yl Chemical group 0.000 claims description 87
125000001072 heteroaryl group Chemical group 0.000 claims description 73
125000000217 alkyl group Chemical group 0.000 claims description 70
239000000203 mixture Substances 0.000 claims description 62
125000000623 heterocyclic group Chemical group 0.000 claims description 59
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 57
125000003118 aryl group Chemical group 0.000 claims description 56
229920002554 vinyl polymer Polymers 0.000 claims description 56
239000001257 hydrogen Substances 0.000 claims description 48
229910052739 hydrogen Inorganic materials 0.000 claims description 48
125000000753 cycloalkyl group Chemical group 0.000 claims description 45
125000003342 alkenyl group Chemical group 0.000 claims description 41
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 39
125000001188 haloalkyl group Chemical group 0.000 claims description 37
150000002431 hydrogen Chemical class 0.000 claims description 36
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 34
208000002193 Pain Diseases 0.000 claims description 32
125000003710 aryl alkyl group Chemical group 0.000 claims description 31
150000003839 salts Chemical class 0.000 claims description 31
125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 26
239000011734 sodium Substances 0.000 claims description 25
125000004446 heteroarylalkyl group Chemical group 0.000 claims description 23
125000004415 heterocyclylalkyl group Chemical group 0.000 claims description 23
125000004966 cyanoalkyl group Chemical group 0.000 claims description 22
125000000392 cycloalkenyl group Chemical group 0.000 claims description 22
125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims description 22
208000035475 disorder Diseases 0.000 claims description 20
201000010099 disease Diseases 0.000 claims description 19
229910052757 nitrogen Inorganic materials 0.000 claims description 19
229910052736 halogen Inorganic materials 0.000 claims description 18
150000002367 halogens Chemical class 0.000 claims description 18
229910052708 sodium Inorganic materials 0.000 claims description 16
125000000304 alkynyl group Chemical group 0.000 claims description 14
125000004093 cyano group Chemical group *C#N 0.000 claims description 14
239000008194 pharmaceutical composition Substances 0.000 claims description 14
125000003545 alkoxy group Chemical group 0.000 claims description 13
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 13
239000011591 potassium Substances 0.000 claims description 12
229910052700 potassium Inorganic materials 0.000 claims description 12
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 11
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 10
239000003513 alkali Substances 0.000 claims description 10
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 9
125000004183 alkoxy alkyl group Chemical group 0.000 claims description 9
229910052744 lithium Inorganic materials 0.000 claims description 9
125000004433 nitrogen atom Chemical group N* 0.000 claims description 9
230000006870 function Effects 0.000 claims description 8
208000004296 neuralgia Diseases 0.000 claims description 8
229910052760 oxygen Inorganic materials 0.000 claims description 8
239000000546 pharmaceutical excipient Substances 0.000 claims description 8
125000001331 3-methylbutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 claims description 7
125000004104 aryloxy group Chemical group 0.000 claims description 7
206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 6
125000000000 cycloalkoxy group Chemical group 0.000 claims description 6
239000003085 diluting agent Substances 0.000 claims description 6
PKBYSNWDIFBUJW-VAWYXSNFSA-N n-(4-tert-butyl-1,3-thiazol-2-yl)-6-[(e)-2-[2-(2,2-dimethylpropoxy)-3-methoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(=O)NC=2SC=C(N=2)C(C)(C)C)=C1OCC(C)(C)C PKBYSNWDIFBUJW-VAWYXSNFSA-N 0.000 claims description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
201000008482 osteoarthritis Diseases 0.000 claims description 6
229910052717 sulfur Inorganic materials 0.000 claims description 6
208000024891 symptom Diseases 0.000 claims description 6
208000000094 Chronic Pain Diseases 0.000 claims description 5
208000004550 Postoperative Pain Diseases 0.000 claims description 5
208000005298 acute pain Diseases 0.000 claims description 5
238000003556 assay Methods 0.000 claims description 5
208000021722 neuropathic pain Diseases 0.000 claims description 5
206010039073 rheumatoid arthritis Diseases 0.000 claims description 5
208000011580 syndromic disease Diseases 0.000 claims description 5
238000012360 testing method Methods 0.000 claims description 5
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
206010020751 Hypersensitivity Diseases 0.000 claims description 4
208000026935 allergic disease Diseases 0.000 claims description 4
230000000172 allergic effect Effects 0.000 claims description 4
206010003246 arthritis Diseases 0.000 claims description 4
230000009610 hypersensitivity Effects 0.000 claims description 4
230000001404 mediated effect Effects 0.000 claims description 4
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 4
208000004371 toothache Diseases 0.000 claims description 4
OOFSAZADFPZLIW-MDZDMXLPSA-N 6-[(e)-2-(2-cyclopentyloxy-3-methoxyphenyl)ethenyl]-n-[4-(trifluoromethyl)-1,3-thiazol-2-yl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound C1CCCC1OC=1C(OC)=CC=CC=1\C=C\C=1N=C2SC=CN2C=1C(=O)NC1=NC(C(F)(F)F)=CS1 OOFSAZADFPZLIW-MDZDMXLPSA-N 0.000 claims description 3
ABMONLDJYBIDKQ-MDZDMXLPSA-N 6-[(e)-2-[2-(2,2-dimethylpropoxy)-3-methoxyphenyl]ethenyl]-n-(4-methyl-1,3-thiazol-2-yl)imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(=O)NC=2SC=C(C)N=2)=C1OCC(C)(C)C ABMONLDJYBIDKQ-MDZDMXLPSA-N 0.000 claims description 3
UYERHYJUWPGGIN-CMDGGOBGSA-N 6-[(e)-2-[2-(2,2-dimethylpropoxy)-3-methoxyphenyl]ethenyl]-n-[4-(trifluoromethyl)-1,3-thiazol-2-yl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(=O)NC=2SC=C(N=2)C(F)(F)F)=C1OCC(C)(C)C UYERHYJUWPGGIN-CMDGGOBGSA-N 0.000 claims description 3
ABSXFDMTOKOQBO-MDZDMXLPSA-N 6-[(e)-2-[2-(cyclobutylmethoxy)-3-(difluoromethoxy)phenyl]ethenyl]-n-(4-cyclopropyl-1,3-thiazol-2-yl)imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound C1CCC1COC=1C(OC(F)F)=CC=CC=1\C=C\C=1N=C2SC=CN2C=1C(=O)NC(SC=1)=NC=1C1CC1 ABSXFDMTOKOQBO-MDZDMXLPSA-N 0.000 claims description 3
SHZQUNAWQAVJJZ-KPKJPENVSA-N 6-[(e)-2-[2-(cyclopropylmethoxy)-3-methoxyphenyl]ethenyl]-n-[4-(trifluoromethoxy)phenyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound C1CC1COC=1C(OC)=CC=CC=1\C=C\C=1N=C2SC=CN2C=1C(=O)NC1=CC=C(OC(F)(F)F)C=C1 SHZQUNAWQAVJJZ-KPKJPENVSA-N 0.000 claims description 3
FELPHWAWJAUCAY-BQYQJAHWSA-N 6-[(e)-2-[2-(cyclopropylmethoxy)-3-methoxyphenyl]ethenyl]-n-[4-(trifluoromethyl)-1,3-thiazol-2-yl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound C1CC1COC=1C(OC)=CC=CC=1\C=C\C=1N=C2SC=CN2C=1C(=O)NC1=NC(C(F)(F)F)=CS1 FELPHWAWJAUCAY-BQYQJAHWSA-N 0.000 claims description 3
KONLPBXOQIVYIA-CMDGGOBGSA-N 6-[(e)-2-[2-cyclopentyloxy-3-(difluoromethoxy)phenyl]ethenyl]-n-[4-(trifluoromethyl)-1,3-thiazol-2-yl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound C1CCCC1OC=1C(OC(F)F)=CC=CC=1\C=C\C=1N=C2SC=CN2C=1C(=O)NC1=NC(C(F)(F)F)=CS1 KONLPBXOQIVYIA-CMDGGOBGSA-N 0.000 claims description 3
MSIPQSOAPYZROY-BQYQJAHWSA-N 6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]-n-(2,2,2-trifluoroethyl)imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NCC(F)(F)F)N2C=CSC2=N1 MSIPQSOAPYZROY-BQYQJAHWSA-N 0.000 claims description 3
NOTUPWMMXIVDAK-MDZDMXLPSA-N 6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]-n-(4-propan-2-yl-1,3-thiazol-2-yl)imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)C1=CSC(NC(=O)C=2N3C=CSC3=NC=2\C=C\C=2C(=C(OC(F)F)C=CC=2)OCC(C)(C)C)=N1 NOTUPWMMXIVDAK-MDZDMXLPSA-N 0.000 claims description 3
HVEWWSZNDCOJAM-ZHACJKMWSA-N 6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]-n-(5,6-dihydro-4h-cyclopenta[d][1,3]thiazol-2-yl)imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NC=2SC=3CCCC=3N=2)N2C=CSC2=N1 HVEWWSZNDCOJAM-ZHACJKMWSA-N 0.000 claims description 3
UUVOTZSPVFEKNH-VQHVLOKHSA-N 6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]-n-(6-fluoro-1,3-benzothiazol-2-yl)imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NC=2SC3=CC(F)=CC=C3N=2)N2C=CSC2=N1 UUVOTZSPVFEKNH-VQHVLOKHSA-N 0.000 claims description 3
WJVGOERDXLNBJH-ZHACJKMWSA-N 6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]-n-[[3-(trifluoromethyl)phenyl]methyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NCC=2C=C(C=CC=2)C(F)(F)F)N2C=CSC2=N1 WJVGOERDXLNBJH-ZHACJKMWSA-N 0.000 claims description 3
ZSGGLLMMFYVSFX-BQYQJAHWSA-N 6-[(e)-2-[3-methoxy-2-(2-methylpropoxy)phenyl]ethenyl]-n-[4-(trifluoromethyl)-1,3-thiazol-2-yl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(=O)NC=2SC=C(N=2)C(F)(F)F)=C1OCC(C)C ZSGGLLMMFYVSFX-BQYQJAHWSA-N 0.000 claims description 3
201000004384 Alopecia Diseases 0.000 claims description 3
208000019901 Anxiety disease Diseases 0.000 claims description 3
208000006820 Arthralgia Diseases 0.000 claims description 3
206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 3
OYPRJOBELJOOCE-BKFZFHPZSA-N Calcium-45 Chemical compound [45Ca] OYPRJOBELJOOCE-BKFZFHPZSA-N 0.000 claims description 3
206010058019 Cancer Pain Diseases 0.000 claims description 3
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 3
208000015943 Coeliac disease Diseases 0.000 claims description 3
208000011231 Crohn disease Diseases 0.000 claims description 3
206010012289 Dementia Diseases 0.000 claims description 3
201000004624 Dermatitis Diseases 0.000 claims description 3
208000032131 Diabetic Neuropathies Diseases 0.000 claims description 3
208000004232 Enteritis Diseases 0.000 claims description 3
208000018522 Gastrointestinal disease Diseases 0.000 claims description 3
208000023105 Huntington disease Diseases 0.000 claims description 3
206010061218 Inflammation Diseases 0.000 claims description 3
208000022559 Inflammatory bowel disease Diseases 0.000 claims description 3
208000027530 Meniere disease Diseases 0.000 claims description 3
208000019695 Migraine disease Diseases 0.000 claims description 3
208000007101 Muscle Cramp Diseases 0.000 claims description 3
208000001294 Nociceptive Pain Diseases 0.000 claims description 3
208000008589 Obesity Diseases 0.000 claims description 3
206010033645 Pancreatitis Diseases 0.000 claims description 3
208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 3
208000017442 Retinal disease Diseases 0.000 claims description 3
206010038923 Retinopathy Diseases 0.000 claims description 3
ZDFIDBBCRXNMST-UHFFFAOYSA-N S1C=2N(C=C1)C(=CN2)C(=O)N2CC=1N(CC2)C(=NN1)C(F)(F)F Chemical compound S1C=2N(C=C1)C(=CN2)C(=O)N2CC=1N(CC2)C(=NN1)C(F)(F)F ZDFIDBBCRXNMST-UHFFFAOYSA-N 0.000 claims description 3
208000005392 Spasm Diseases 0.000 claims description 3
108010062740 TRPV Cation Channels Proteins 0.000 claims description 3
102000011040 TRPV Cation Channels Human genes 0.000 claims description 3
208000009205 Tinnitus Diseases 0.000 claims description 3
206010060875 Uraemic pruritus Diseases 0.000 claims description 3
206010046543 Urinary incontinence Diseases 0.000 claims description 3
208000024780 Urticaria Diseases 0.000 claims description 3
206010047700 Vomiting Diseases 0.000 claims description 3
OJPGXZVQULKRIG-BUHFOSPRSA-N [6-[(e)-2-[2-(cyclopropylmethoxy)-3-methoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazol-5-yl]-(3,4-dihydro-2h-quinolin-1-yl)methanone Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(=O)N2C3=CC=CC=C3CCC2)=C1OCC1CC1 OJPGXZVQULKRIG-BUHFOSPRSA-N 0.000 claims description 3
231100000360 alopecia Toxicity 0.000 claims description 3
208000006673 asthma Diseases 0.000 claims description 3
230000036760 body temperature Effects 0.000 claims description 3
230000003925 brain function Effects 0.000 claims description 3
206010012601 diabetes mellitus Diseases 0.000 claims description 3
210000001508 eye Anatomy 0.000 claims description 3
208000021302 gastroesophageal reflux disease Diseases 0.000 claims description 3
208000009326 ileitis Diseases 0.000 claims description 3
208000027866 inflammatory disease Diseases 0.000 claims description 3
230000004054 inflammatory process Effects 0.000 claims description 3
208000002551 irritable bowel syndrome Diseases 0.000 claims description 3
230000007794 irritation Effects 0.000 claims description 3
230000000302 ischemic effect Effects 0.000 claims description 3
206010027175 memory impairment Diseases 0.000 claims description 3
206010027599 migraine Diseases 0.000 claims description 3
210000004400 mucous membrane Anatomy 0.000 claims description 3
210000004165 myocardium Anatomy 0.000 claims description 3
GLARRLPLBDDBOF-CMDGGOBGSA-N n-(2-cyanoethyl)-6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NCCC#N)N2C=CSC2=N1 GLARRLPLBDDBOF-CMDGGOBGSA-N 0.000 claims description 3
CTWMFVBCEDTCQE-ZHACJKMWSA-N n-(4-cyclobutyl-1,3-thiazol-2-yl)-6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NC=2SC=C(N=2)C2CCC2)N2C=CSC2=N1 CTWMFVBCEDTCQE-ZHACJKMWSA-N 0.000 claims description 3
NTUFRDLXFHYONC-CMDGGOBGSA-N n-(5-cyanopyridin-2-yl)-6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NC=2N=CC(=CC=2)C#N)N2C=CSC2=N1 NTUFRDLXFHYONC-CMDGGOBGSA-N 0.000 claims description 3
KLPUJMXCSQYYHV-BQYQJAHWSA-N n-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NC=2C(=CC(=CN=2)C(F)(F)F)Cl)N2C=CSC2=N1 KLPUJMXCSQYYHV-BQYQJAHWSA-N 0.000 claims description 3
HDGPJQJLFCVOHK-OUKQBFOZSA-N n-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-6-[(e)-2-[2-(2,2-dimethylpropoxy)-3-methoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(=O)NC=2SC=C(N=2)C=2C=CC(=CC=2)C#N)=C1OCC(C)(C)C HDGPJQJLFCVOHK-OUKQBFOZSA-N 0.000 claims description 3
230000004770 neurodegeneration Effects 0.000 claims description 3
201000001119 neuropathy Diseases 0.000 claims description 3
230000007823 neuropathy Effects 0.000 claims description 3
235000020824 obesity Nutrition 0.000 claims description 3
208000033808 peripheral neuropathy Diseases 0.000 claims description 3
230000001823 pruritic effect Effects 0.000 claims description 3
208000023504 respiratory system disease Diseases 0.000 claims description 3
231100000886 tinnitus Toxicity 0.000 claims description 3
206010044652 trigeminal neuralgia Diseases 0.000 claims description 3
230000008673 vomiting Effects 0.000 claims description 3
210000003905 vulva Anatomy 0.000 claims description 3
RLWIXOQDBILIDJ-UHFFFAOYSA-N 4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbaldehyde Chemical compound N1=CC(C(F)(F)F)=CC=C1N1CCN(C=O)CC1 RLWIXOQDBILIDJ-UHFFFAOYSA-N 0.000 claims description 2
MCOWLMHLGJJRSG-BQYQJAHWSA-N 6-[(e)-2-[2-(cyclobutylmethoxy)-3-(difluoromethoxy)phenyl]ethenyl]-n-[4-(trifluoromethyl)-1,3-thiazol-2-yl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound C1CCC1COC=1C(OC(F)F)=CC=CC=1\C=C\C=1N=C2SC=CN2C=1C(=O)NC1=NC(C(F)(F)F)=CS1 MCOWLMHLGJJRSG-BQYQJAHWSA-N 0.000 claims description 2
OZCTXGZFQBMDLX-CMDGGOBGSA-N 6-[4-[6-[(e)-2-[2-(cyclopropylmethoxy)-3-methoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carbonyl]piperazin-1-yl]pyridine-3-carbonitrile Chemical compound C1CC1COC=1C(OC)=CC=CC=1\C=C\C=1N=C2SC=CN2C=1C(=O)N(CC1)CCN1C1=CC=C(C#N)C=N1 OZCTXGZFQBMDLX-CMDGGOBGSA-N 0.000 claims description 2
206010017886 Gastroduodenal ulcer Diseases 0.000 claims description 2
206010020649 Hyperkeratosis Diseases 0.000 claims description 2
208000001126 Keratosis Diseases 0.000 claims description 2
208000008469 Peptic Ulcer Diseases 0.000 claims description 2
206010039085 Rhinitis allergic Diseases 0.000 claims description 2
201000010105 allergic rhinitis Diseases 0.000 claims description 2
231100000029 gastro-duodenal ulcer Toxicity 0.000 claims description 2
YVYVROKOAMOIBN-OUKQBFOZSA-N n-(4-cyclopropyl-1,3-thiazol-2-yl)-2-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NC=2SC=C(N=2)C2CC2)N2C=CC=CC2=N1 YVYVROKOAMOIBN-OUKQBFOZSA-N 0.000 claims description 2
208000037916 non-allergic rhinitis Diseases 0.000 claims description 2
125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 2
102000003568 TRPV3 Human genes 0.000 claims 2
101150043371 Trpv3 gene Proteins 0.000 claims 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
206010020559 Hyperacusis Diseases 0.000 claims 1
206010023347 Keratoacanthoma Diseases 0.000 claims 1
239000012458 free base Substances 0.000 claims 1
ZMBYQTGAXZOMOO-UHFFFAOYSA-N imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C1=CC=CN2C(C(=O)N)=CN=C21 ZMBYQTGAXZOMOO-UHFFFAOYSA-N 0.000 claims 1
230000002265 prevention Effects 0.000 claims 1
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 119
239000000543 intermediate Substances 0.000 description 114
238000000034 method Methods 0.000 description 100
239000007787 solid Substances 0.000 description 82
239000000047 product Substances 0.000 description 75
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 72
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 58
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 58
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 58
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 41
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 39
238000000668 atmospheric pressure chemical ionisation mass spectrometry Methods 0.000 description 38
IXWOUPGDGMCKGT-UHFFFAOYSA-N 2,3-dihydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1O IXWOUPGDGMCKGT-UHFFFAOYSA-N 0.000 description 36
229960000549 4-dimethylaminophenol Drugs 0.000 description 36
238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 35
239000002904 solvent Substances 0.000 description 31
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 30
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
239000002585 base Substances 0.000 description 20
239000000243 solution Substances 0.000 description 18
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
230000008878 coupling Effects 0.000 description 17
238000010168 coupling process Methods 0.000 description 17
238000005859 coupling reaction Methods 0.000 description 17
JJVNINGBHGBWJH-UHFFFAOYSA-N ortho-vanillin Chemical compound COC1=CC=CC(C=O)=C1O JJVNINGBHGBWJH-UHFFFAOYSA-N 0.000 description 17
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
150000001412 amines Chemical class 0.000 description 15
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
OVMGTNMCYLZGLS-UHFFFAOYSA-N 4-(trifluoromethyl)-1,3-thiazol-2-amine Chemical compound NC1=NC(C(F)(F)F)=CS1 OVMGTNMCYLZGLS-UHFFFAOYSA-N 0.000 description 14
229910000104 sodium hydride Inorganic materials 0.000 description 14
238000002360 preparation method Methods 0.000 description 13
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 11
150000001732 carboxylic acid derivatives Chemical class 0.000 description 11
239000011541 reaction mixture Substances 0.000 description 11
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 10
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
239000012312 sodium hydride Substances 0.000 description 10
125000001424 substituent group Chemical group 0.000 description 10
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
125000004432 carbon atom Chemical group C* 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 9
239000010410 layer Substances 0.000 description 9
229910052799 carbon Inorganic materials 0.000 description 8
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 8
239000000725 suspension Substances 0.000 description 8
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
239000002253 acid Substances 0.000 description 7
239000012267 brine Substances 0.000 description 7
210000004027 cell Anatomy 0.000 description 7
125000004122 cyclic group Chemical group 0.000 description 7
239000003814 drug Substances 0.000 description 7
238000001704 evaporation Methods 0.000 description 7
230000008020 evaporation Effects 0.000 description 7
108020003175 receptors Proteins 0.000 description 7
102000005962 receptors Human genes 0.000 description 7
238000010898 silica gel chromatography Methods 0.000 description 7
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
0 C/C1=C(/*2)\C=C2/C(/CCc2c(C(*)=O)[n]c(*)n2)=C/C=C1 Chemical compound C/C1=C(/*2)\C=C2/C(/CCc2c(C(*)=O)[n]c(*)n2)=C/C=C1 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 6
150000001408 amides Chemical class 0.000 description 6
125000002619 bicyclic group Chemical group 0.000 description 6
239000002775 capsule Substances 0.000 description 6
150000001721 carbon Chemical group 0.000 description 6
239000007822 coupling agent Substances 0.000 description 6
239000012044 organic layer Substances 0.000 description 6
239000003208 petroleum Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 5
BLZVCIGGICSWIG-UHFFFAOYSA-N 2-aminoethoxydiphenylborane Chemical compound C=1C=CC=CC=1B(OCCN)C1=CC=CC=C1 BLZVCIGGICSWIG-UHFFFAOYSA-N 0.000 description 5
ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 5
108091006146 Channels Proteins 0.000 description 5
108010010803 Gelatin Proteins 0.000 description 5
241001465754 Metazoa Species 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
229920000159 gelatin Polymers 0.000 description 5
235000019322 gelatine Nutrition 0.000 description 5
235000011852 gelatine desserts Nutrition 0.000 description 5
230000007062 hydrolysis Effects 0.000 description 5
238000006460 hydrolysis reaction Methods 0.000 description 5
125000004356 hydroxy functional group Chemical group O* 0.000 description 5
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
229910000027 potassium carbonate Inorganic materials 0.000 description 5
108091053409 transient receptor (TC 1.A.4) family Proteins 0.000 description 5
102000042565 transient receptor (TC 1.A.4) family Human genes 0.000 description 5
DDEBSQUTYSPZGA-UHFFFAOYSA-M (5-ethoxycarbonylimidazo[2,1-b][1,3]thiazol-6-yl)methyl-triphenylphosphanium;bromide Chemical compound [Br-].N1=C2SC=CN2C(C(=O)OCC)=C1C[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 DDEBSQUTYSPZGA-UHFFFAOYSA-M 0.000 description 4
LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 4
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
FGPNVCRMNYEMEP-UHFFFAOYSA-N 4-cyclopropyl-1,3-thiazol-2-amine Chemical compound S1C(N)=NC(C2CC2)=C1 FGPNVCRMNYEMEP-UHFFFAOYSA-N 0.000 description 4
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
229960000583 acetic acid Drugs 0.000 description 4
150000001413 amino acids Chemical group 0.000 description 4
238000004440 column chromatography Methods 0.000 description 4
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 4
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 4
235000014113 dietary fatty acids Nutrition 0.000 description 4
125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 4
230000000694 effects Effects 0.000 description 4
150000002148 esters Chemical class 0.000 description 4
239000000194 fatty acid Substances 0.000 description 4
229930195729 fatty acid Natural products 0.000 description 4
125000005842 heteroatom Chemical group 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
239000002609 medium Substances 0.000 description 4
239000001301 oxygen Substances 0.000 description 4
150000003254 radicals Chemical class 0.000 description 4
238000010992 reflux Methods 0.000 description 4
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 3
KNQWMTMQTABJOV-UHFFFAOYSA-N 2-cyclopentyloxy-3-(difluoromethoxy)benzaldehyde Chemical compound FC(F)OC1=CC=CC(C=O)=C1OC1CCCC1 KNQWMTMQTABJOV-UHFFFAOYSA-N 0.000 description 3
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
238000007239 Wittig reaction Methods 0.000 description 3
229910052783 alkali metal Inorganic materials 0.000 description 3
150000001350 alkyl halides Chemical class 0.000 description 3
230000029936 alkylation Effects 0.000 description 3
238000005804 alkylation reaction Methods 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 3
229910000024 caesium carbonate Inorganic materials 0.000 description 3
239000011575 calcium Substances 0.000 description 3
239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
239000012043 crude product Substances 0.000 description 3
GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
125000002883 imidazolyl group Chemical group 0.000 description 3
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
125000002950 monocyclic group Chemical group 0.000 description 3
HHQJWDKIRXRTLS-UHFFFAOYSA-N n'-bromobutanediamide Chemical compound NC(=O)CCC(=O)NBr HHQJWDKIRXRTLS-UHFFFAOYSA-N 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
125000004193 piperazinyl group Chemical group 0.000 description 3
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
238000000746 purification Methods 0.000 description 3
239000011877 solvent mixture Substances 0.000 description 3
230000002194 synthesizing effect Effects 0.000 description 3
239000003826 tablet Substances 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 2
YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 2
DEPDDPLQZYCHOH-UHFFFAOYSA-N 1h-imidazol-2-amine Chemical compound NC1=NC=CN1 DEPDDPLQZYCHOH-UHFFFAOYSA-N 0.000 description 2
IICDFWWJDOWCJA-VAWYXSNFSA-N 2-[(e)-2-[2-(2,2-dimethylpropoxy)-3-methoxyphenyl]ethenyl]imidazo[1,2-a]pyridine-3-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CC=CC3=N2)C(O)=O)=C1OCC(C)(C)C IICDFWWJDOWCJA-VAWYXSNFSA-N 0.000 description 2
RJTLQVKXLZOSLL-ZHACJKMWSA-N 2-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[1,2-a]pyridine-3-carboxylic acid Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(O)=O)N2C=CC=CC2=N1 RJTLQVKXLZOSLL-ZHACJKMWSA-N 0.000 description 2
AQONRRNROVXONL-MDZDMXLPSA-N 2-[(e)-2-[3-(difluoromethoxy)-2-(3-methylbutoxy)phenyl]ethenyl]imidazo[1,2-a]pyridine-3-carboxylic acid Chemical compound CC(C)CCOC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(O)=O)N2C=CC=CC2=N1 AQONRRNROVXONL-MDZDMXLPSA-N 0.000 description 2
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 description 2
LUSFWEXIRSHBNN-UHFFFAOYSA-N 4-(trifluoromethyl)-1,3-oxazol-2-amine Chemical compound NC1=NC(C(F)(F)F)=CO1 LUSFWEXIRSHBNN-UHFFFAOYSA-N 0.000 description 2
QCOWZNYRWUSFPN-UHFFFAOYSA-N 4-cyclobutyl-1,3-thiazol-2-amine Chemical compound S1C(N)=NC(C2CCC2)=C1 QCOWZNYRWUSFPN-UHFFFAOYSA-N 0.000 description 2
CUWZBHVYLVGOAB-UHFFFAOYSA-N 4-tert-butyl-1,3-thiazol-2-amine Chemical compound CC(C)(C)C1=CSC(N)=N1 CUWZBHVYLVGOAB-UHFFFAOYSA-N 0.000 description 2
APBQBCIHZIGVGM-MDZDMXLPSA-N 6-[(e)-2-(2-cyclopentyloxy-3-methoxyphenyl)ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(O)=O)=C1OC1CCCC1 APBQBCIHZIGVGM-MDZDMXLPSA-N 0.000 description 2
FFFBOKNRCBTGBB-BQYQJAHWSA-N 6-[(e)-2-[2-(cyclopropylmethoxy)-3-methoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(O)=O)=C1OCC1CC1 FFFBOKNRCBTGBB-BQYQJAHWSA-N 0.000 description 2
CKOGPVAHSLTGAI-CMDGGOBGSA-N 6-[(e)-2-[2-cyclopentyloxy-3-(difluoromethoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound N1=C2SC=CN2C(C(=O)O)=C1\C=C\C1=CC=CC(OC(F)F)=C1OC1CCCC1 CKOGPVAHSLTGAI-CMDGGOBGSA-N 0.000 description 2
VXTGLFQIPSACSF-BQYQJAHWSA-N 6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(O)=O)N2C=CSC2=N1 VXTGLFQIPSACSF-BQYQJAHWSA-N 0.000 description 2
SYMKBOQLAWPRGG-VOTSOKGWSA-N 6-[(e)-2-[3-(difluoromethoxy)-2-(3-methylbutoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound CC(C)CCOC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(O)=O)N2C=CSC2=N1 SYMKBOQLAWPRGG-VOTSOKGWSA-N 0.000 description 2
PRWQTIYXQKRTJT-CMDGGOBGSA-N 6-[(e)-2-[3-(difluoromethoxy)-2-pentoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound CCCCCOC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(O)=O)N2C=CSC2=N1 PRWQTIYXQKRTJT-CMDGGOBGSA-N 0.000 description 2
BCUCKOLNSPPDFF-BQYQJAHWSA-N 6-[(e)-2-[3-methoxy-2-(2-methylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(O)=O)=C1OCC(C)C BCUCKOLNSPPDFF-BQYQJAHWSA-N 0.000 description 2
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
239000005973 Carvone Substances 0.000 description 2
108091005462 Cation channels Proteins 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000633107 Homo sapiens Transient receptor potential cation channel subfamily V member 3 Proteins 0.000 description 2
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
108060008564 TRPV Proteins 0.000 description 2
102000003563 TRPV Human genes 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
150000001299 aldehydes Chemical class 0.000 description 2
150000004703 alkoxides Chemical class 0.000 description 2
239000005557 antagonist Substances 0.000 description 2
238000013459 approach Methods 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
208000010668 atopic eczema Diseases 0.000 description 2
230000008901 benefit Effects 0.000 description 2
HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
RROBIDXNTUAHFW-UHFFFAOYSA-N benzotriazol-1-yloxy-tris(dimethylamino)phosphanium Chemical compound C1=CC=C2N(O[P+](N(C)C)(N(C)C)N(C)C)N=NC2=C1 RROBIDXNTUAHFW-UHFFFAOYSA-N 0.000 description 2
ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
239000000872 buffer Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
229910001424 calcium ion Inorganic materials 0.000 description 2
230000003185 calcium uptake Effects 0.000 description 2
239000000969 carrier Substances 0.000 description 2
239000004359 castor oil Substances 0.000 description 2
235000019438 castor oil Nutrition 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 2
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
239000008298 dragée Substances 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
NKBSVNAAVHCEMD-MDZDMXLPSA-N ethyl 2-[(e)-2-[3-(difluoromethoxy)-2-hydroxyphenyl]ethenyl]imidazo[1,2-a]pyridine-3-carboxylate Chemical compound N1=C2C=CC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC(F)F)=C1O NKBSVNAAVHCEMD-MDZDMXLPSA-N 0.000 description 2
239000002024 ethyl acetate extract Substances 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000012362 glacial acetic acid Substances 0.000 description 2
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
125000004438 haloalkoxy group Chemical group 0.000 description 2
230000002140 halogenating effect Effects 0.000 description 2
230000026030 halogenation Effects 0.000 description 2
238000005658 halogenation reaction Methods 0.000 description 2
125000005241 heteroarylamino group Chemical group 0.000 description 2
102000052198 human TRPV3 Human genes 0.000 description 2
125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000012669 liquid formulation Substances 0.000 description 2
239000007937 lozenge Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
229910052987 metal hydride Inorganic materials 0.000 description 2
150000004681 metal hydrides Chemical class 0.000 description 2
229910000000 metal hydroxide Inorganic materials 0.000 description 2
150000004692 metal hydroxides Chemical class 0.000 description 2
UVPCUABIQGQLEU-MDZDMXLPSA-N n-(4-cyclopropyl-1,3-thiazol-2-yl)-6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound CC(C)(C)COC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)NC=2SC=C(N=2)C2CC2)N2C=CSC2=N1 UVPCUABIQGQLEU-MDZDMXLPSA-N 0.000 description 2
239000012299 nitrogen atmosphere Substances 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
229910052698 phosphorus Inorganic materials 0.000 description 2
239000011574 phosphorus Chemical group 0.000 description 2
NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 2
229910000105 potassium hydride Inorganic materials 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
125000004076 pyridyl group Chemical group 0.000 description 2
230000004044 response Effects 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
239000012047 saturated solution Substances 0.000 description 2
238000012216 screening Methods 0.000 description 2
238000000926 separation method Methods 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
239000000126 substance Substances 0.000 description 2
125000003107 substituted aryl group Chemical group 0.000 description 2
239000011593 sulfur Chemical group 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
102000038650 voltage-gated calcium channel activity Human genes 0.000 description 2
108091023044 voltage-gated calcium channel activity Proteins 0.000 description 2
OTMZZGXWTKIEJF-UHFFFAOYSA-M (3-ethoxycarbonylimidazo[1,2-a]pyridin-2-yl)methyl-triphenylphosphanium;bromide Chemical compound [Br-].N1=C2C=CC=CN2C(C(=O)OCC)=C1C[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 OTMZZGXWTKIEJF-UHFFFAOYSA-M 0.000 description 1
FBZRFGCSSPQVBB-UHFFFAOYSA-M (5-ethoxycarbonylimidazo[1,2-a]pyridin-2-yl)methyl-triphenylphosphanium;bromide Chemical compound [Br-].C=1N2C(C(=O)OCC)=CC=CC2=NC=1C[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 FBZRFGCSSPQVBB-UHFFFAOYSA-M 0.000 description 1
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
YQEWVLFLXWNJMY-UHFFFAOYSA-N 1,3,4-oxadiazol-2-amine;1h-1,2,4-triazol-5-amine Chemical compound NC=1N=CNN=1.NC1=NN=CO1 YQEWVLFLXWNJMY-UHFFFAOYSA-N 0.000 description 1
QUKGLNCXGVWCJX-UHFFFAOYSA-N 1,3,4-thiadiazol-2-amine Chemical compound NC1=NN=CS1 QUKGLNCXGVWCJX-UHFFFAOYSA-N 0.000 description 1
JPBLHOJFMBOCAF-UHFFFAOYSA-N 1,3-benzoxazol-2-amine Chemical compound C1=CC=C2OC(N)=NC2=C1 JPBLHOJFMBOCAF-UHFFFAOYSA-N 0.000 description 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
ACTKAGSPIFDCMF-UHFFFAOYSA-N 1,3-oxazol-2-amine Chemical compound NC1=NC=CO1 ACTKAGSPIFDCMF-UHFFFAOYSA-N 0.000 description 1
MSSDTZLYNMFTKN-UHFFFAOYSA-N 1-Piperazinecarboxaldehyde Chemical compound O=CN1CCNCC1 MSSDTZLYNMFTKN-UHFFFAOYSA-N 0.000 description 1
CQWYAXCOVZKLHY-UHFFFAOYSA-N 1-bromo-2,2-dimethylpropane Chemical compound CC(C)(C)CBr CQWYAXCOVZKLHY-UHFFFAOYSA-N 0.000 description 1
YZWKKMVJZFACSU-UHFFFAOYSA-N 1-bromopentane Chemical compound CCCCCBr YZWKKMVJZFACSU-UHFFFAOYSA-N 0.000 description 1
125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
125000006017 1-propenyl group Chemical group 0.000 description 1
NMIZONYLXCOHEF-UHFFFAOYSA-N 1h-imidazole-2-carboxamide Chemical class NC(=O)C1=NC=CN1 NMIZONYLXCOHEF-UHFFFAOYSA-N 0.000 description 1
KYWMCFOWDYFYLV-UHFFFAOYSA-N 1h-imidazole-2-carboxylic acid Chemical compound OC(=O)C1=NC=CN1 KYWMCFOWDYFYLV-UHFFFAOYSA-N 0.000 description 1
WSBSGFMROYPYPX-UHFFFAOYSA-N 2-(2,2-dimethylpropoxy)-3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1OCC(C)(C)C WSBSGFMROYPYPX-UHFFFAOYSA-N 0.000 description 1
VBZBISQOWJYWCC-UHFFFAOYSA-N 2-(2-carboxypropan-2-yldiazenyl)-2-methylpropanoic acid Chemical compound OC(=O)C(C)(C)N=NC(C)(C)C(O)=O VBZBISQOWJYWCC-UHFFFAOYSA-N 0.000 description 1
VFWBDIPOMLBVTE-UHFFFAOYSA-N 2-(cyclopropylmethoxy)-3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1OCC1CC1 VFWBDIPOMLBVTE-UHFFFAOYSA-N 0.000 description 1
JWYUFVNJZUSCSM-UHFFFAOYSA-N 2-aminobenzimidazole Chemical compound C1=CC=C2NC(N)=NC2=C1 JWYUFVNJZUSCSM-UHFFFAOYSA-N 0.000 description 1
UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 1
150000003930 2-aminopyridines Chemical class 0.000 description 1
APTMRLLOXPDHNL-UHFFFAOYSA-N 2-bromoethyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OCCBr APTMRLLOXPDHNL-UHFFFAOYSA-N 0.000 description 1
125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
KVYXIZHHZDPYQE-UHFFFAOYSA-N 2-cyclopentyloxy-3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1OC1CCCC1 KVYXIZHHZDPYQE-UHFFFAOYSA-N 0.000 description 1
125000006020 2-methyl-1-propenyl group Chemical group 0.000 description 1
125000006088 2-oxoazepinyl group Chemical group 0.000 description 1
125000004638 2-oxopiperazinyl group Chemical group O=C1N(CCNC1)* 0.000 description 1
125000004637 2-oxopiperidinyl group Chemical group O=C1N(CCCC1)* 0.000 description 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
AQCSCRYRCRORET-UHFFFAOYSA-N 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine;hydrochloride Chemical compound Cl.C1NCCN2C(C(F)(F)F)=NN=C21 AQCSCRYRCRORET-UHFFFAOYSA-N 0.000 description 1
VIUDTWATMPPKEL-UHFFFAOYSA-N 3-(trifluoromethyl)aniline Chemical compound NC1=CC=CC(C(F)(F)F)=C1 VIUDTWATMPPKEL-UHFFFAOYSA-N 0.000 description 1
LAMDDILOTVFRLH-VOTSOKGWSA-N 3-[(e)-2-phenylethenyl]imidazo[2,1-b][1,3]thiazole-2-carboxylic acid Chemical compound OC(=O)C=1SC2=NC=CN2C=1\C=C\C1=CC=CC=C1 LAMDDILOTVFRLH-VOTSOKGWSA-N 0.000 description 1
WXNPZQIRDCDLJD-UHFFFAOYSA-N 3-chloro-5-(trifluoromethyl)pyridin-2-amine Chemical compound NC1=NC=C(C(F)(F)F)C=C1Cl WXNPZQIRDCDLJD-UHFFFAOYSA-N 0.000 description 1
CYLWMLRTRHTPFH-UHFFFAOYSA-N 3-methoxy-2-(2-methylpropoxy)benzaldehyde Chemical compound COC1=CC=CC(C=O)=C1OCC(C)C CYLWMLRTRHTPFH-UHFFFAOYSA-N 0.000 description 1
KKMZKOIZTSRIEM-UHFFFAOYSA-N 4-(2-amino-1,3-thiazol-4-yl)benzonitrile Chemical compound S1C(N)=NC(C=2C=CC(=CC=2)C#N)=C1 KKMZKOIZTSRIEM-UHFFFAOYSA-N 0.000 description 1
XUJFOSLZQITUOI-UHFFFAOYSA-N 4-(trifluoromethoxy)aniline Chemical compound NC1=CC=C(OC(F)(F)F)C=C1 XUJFOSLZQITUOI-UHFFFAOYSA-N 0.000 description 1
125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
OUQMXTJYCAJLGO-UHFFFAOYSA-N 4-methyl-1,3-thiazol-2-amine Chemical compound CC1=CSC(N)=N1 OUQMXTJYCAJLGO-UHFFFAOYSA-N 0.000 description 1
BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
125000005986 4-piperidonyl group Chemical group 0.000 description 1
LGPVXXJBWWYOSL-UHFFFAOYSA-N 4-propan-2-yl-1,3-thiazol-2-amine Chemical compound CC(C)C1=CSC(N)=N1 LGPVXXJBWWYOSL-UHFFFAOYSA-N 0.000 description 1
HUKBELGUWQLEFD-UHFFFAOYSA-N 5,6-dihydro-4h-cyclopenta[d][1,3]thiazol-2-amine Chemical compound C1CCC2=C1N=C(N)S2 HUKBELGUWQLEFD-UHFFFAOYSA-N 0.000 description 1
QCCKBDNIBZPFCH-UHFFFAOYSA-N 5,6-dihydro-4h-cyclopenta[d][1,3]thiazole Chemical compound N1=CSC2=C1CCC2 QCCKBDNIBZPFCH-UHFFFAOYSA-N 0.000 description 1
LTEUXHSAYOSFGQ-UHFFFAOYSA-N 5-(trifluoromethyl)-1,3,4-thiadiazol-2-amine Chemical compound NC1=NN=C(C(F)(F)F)S1 LTEUXHSAYOSFGQ-UHFFFAOYSA-N 0.000 description 1
MBGFDWBCSFAVKS-CMDGGOBGSA-N 6-[(e)-2-[2-(2,2-dimethylpropoxy)-3-methoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C2=C(N3C=CSC3=N2)C(O)=O)=C1OCC(C)(C)C MBGFDWBCSFAVKS-CMDGGOBGSA-N 0.000 description 1
LWEUUGLVLIBMFA-BQYQJAHWSA-N 6-[(e)-2-[2-(cyclobutylmethoxy)-3-(difluoromethoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound N1=C2SC=CN2C(C(=O)O)=C1\C=C\C1=CC=CC(OC(F)F)=C1OCC1CCC1 LWEUUGLVLIBMFA-BQYQJAHWSA-N 0.000 description 1
KDVBYUUGYXUXNL-UHFFFAOYSA-N 6-aminopyridine-3-carbonitrile Chemical compound NC1=CC=C(C#N)C=N1 KDVBYUUGYXUXNL-UHFFFAOYSA-N 0.000 description 1
CJLUXPZQUXVJNF-UHFFFAOYSA-N 6-fluoro-1,3-benzothiazol-2-amine Chemical compound C1=C(F)C=C2SC(N)=NC2=C1 CJLUXPZQUXVJNF-UHFFFAOYSA-N 0.000 description 1
BGSRFMFTXMPTSC-UHFFFAOYSA-N 6-fluoro-1,3-benzothiazole Chemical compound FC1=CC=C2N=CSC2=C1 BGSRFMFTXMPTSC-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229920000856 Amylose Polymers 0.000 description 1
239000004342 Benzoyl peroxide Substances 0.000 description 1
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
NCFFCKYFWJWBOR-UHFFFAOYSA-N C(C)C1=CN2C(S1)=NC(=C2)C=CC2=C(C(=CC=C2)OC(F)F)OC2CCCC2 Chemical compound C(C)C1=CN2C(S1)=NC(=C2)C=CC2=C(C(=CC=C2)OC(F)F)OC2CCCC2 NCFFCKYFWJWBOR-UHFFFAOYSA-N 0.000 description 1
OJLSSMFICOMILU-YCPWADLHSA-N C[C@@H](N/C(/C(F)(F)F)=C\S)NC(c1c(/C=C/c(cccc2OC)c2OC2CCCC2)nc2[s]cc[n]12)=O Chemical compound C[C@@H](N/C(/C(F)(F)F)=C\S)NC(c1c(/C=C/c(cccc2OC)c2OC2CCCC2)nc2[s]cc[n]12)=O OJLSSMFICOMILU-YCPWADLHSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 1
229920000858 Cyclodextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
208000012661 Dyskinesia Diseases 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
206010065390 Inflammatory pain Diseases 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
108090000862 Ion Channels Proteins 0.000 description 1
102000004310 Ion Channels Human genes 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
240000007472 Leucaena leucocephala Species 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
239000002841 Lewis acid Substances 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
101100208031 Mus musculus Trpv3 gene Proteins 0.000 description 1
LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
FBESKDOFCKOHBL-UHFFFAOYSA-N S1C=2N(C=C1)C(=CN2)C(=O)NC=2SC=C(N2)C2CC2 Chemical compound S1C=2N(C=C1)C(=CN2)C(=O)NC=2SC=C(N2)C2CC2 FBESKDOFCKOHBL-UHFFFAOYSA-N 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000546339 Trioxys Species 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
NVSPJDGXKBDYIZ-UHFFFAOYSA-N [1,2,4]triazolo[4,3-a]pyrazine Chemical compound C1=NC=CN2C=NN=C21 NVSPJDGXKBDYIZ-UHFFFAOYSA-N 0.000 description 1
YKNZTUQUXUXTLE-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(C(F)(F)F)=C1 YKNZTUQUXUXTLE-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
208000009621 actinic keratosis Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
239000000556 agonist Substances 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
150000005215 alkyl ethers Chemical class 0.000 description 1
125000000746 allylic group Chemical group 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
239000003708 ampul Substances 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
239000000010 aprotic solvent Substances 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
238000011914 asymmetric synthesis Methods 0.000 description 1
125000002785 azepinyl group Chemical group 0.000 description 1
125000002393 azetidinyl group Chemical group 0.000 description 1
150000003935 benzaldehydes Chemical class 0.000 description 1
125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
235000019400 benzoyl peroxide Nutrition 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
AGSPXMVUFBBBMO-UHFFFAOYSA-N beta-aminopropionitrile Chemical compound NCCC#N AGSPXMVUFBBBMO-UHFFFAOYSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000004305 biphenyl Chemical group 0.000 description 1
235000010290 biphenyl Nutrition 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000031709 bromination Effects 0.000 description 1
238000005893 bromination reaction Methods 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
BRTFVKHPEHKBQF-UHFFFAOYSA-N bromocyclopentane Chemical compound BrC1CCCC1 BRTFVKHPEHKBQF-UHFFFAOYSA-N 0.000 description 1
125000005997 bromomethyl group Chemical group 0.000 description 1
FLHFTXCMKFVKRP-UHFFFAOYSA-N bromomethylcyclobutane Chemical compound BrCC1CCC1 FLHFTXCMKFVKRP-UHFFFAOYSA-N 0.000 description 1
125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
230000009460 calcium influx Effects 0.000 description 1
125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
238000003763 carbonization Methods 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
239000004927 clay Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
230000020335 dealkylation Effects 0.000 description 1
238000006900 dealkylation reaction Methods 0.000 description 1
125000005507 decahydroisoquinolyl group Chemical group 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
229940009976 deoxycholate Drugs 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
125000006001 difluoroethyl group Chemical group 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
125000005879 dioxolanyl group Chemical group 0.000 description 1
208000037765 diseases and disorders Diseases 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
208000000718 duodenal ulcer Diseases 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
125000004185 ester group Chemical group 0.000 description 1
JLLFNWXHRYWYSM-UHFFFAOYSA-N ethyl 2-(bromomethyl)imidazo[1,2-a]pyridine-3-carboxylate Chemical compound C1=CC=CN2C(C(=O)OCC)=C(CBr)N=C21 JLLFNWXHRYWYSM-UHFFFAOYSA-N 0.000 description 1
AAZAPSNAPPBNJD-BUHFOSPRSA-N ethyl 2-[(e)-2-[2-cyclopentyloxy-3-(difluoromethoxy)phenyl]ethenyl]imidazo[1,2-a]pyridine-3-carboxylate Chemical compound N1=C2C=CC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC(F)F)=C1OC1CCCC1 AAZAPSNAPPBNJD-BUHFOSPRSA-N 0.000 description 1
GWQJEEGGNHFKOJ-OUKQBFOZSA-N ethyl 2-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[1,2-a]pyridine-3-carboxylate Chemical compound N1=C2C=CC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC(F)F)=C1OCC(C)(C)C GWQJEEGGNHFKOJ-OUKQBFOZSA-N 0.000 description 1
XYGZQUAPCRLJHV-VAWYXSNFSA-N ethyl 2-[(e)-2-[3-(difluoromethoxy)-2-(3-methylbutoxy)phenyl]ethenyl]imidazo[1,2-a]pyridine-3-carboxylate Chemical compound N1=C2C=CC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC(F)F)=C1OCCC(C)C XYGZQUAPCRLJHV-VAWYXSNFSA-N 0.000 description 1
RDULEYWUGKOCMR-UHFFFAOYSA-N ethyl 2-chloro-3-oxobutanoate Chemical compound CCOC(=O)C(Cl)C(C)=O RDULEYWUGKOCMR-UHFFFAOYSA-N 0.000 description 1
FLAQFBICEAEEOA-UHFFFAOYSA-N ethyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate Chemical compound C1=CC=CN2C(C(=O)OCC)=C(C)N=C21 FLAQFBICEAEEOA-UHFFFAOYSA-N 0.000 description 1
RUNMRQIIEIASMK-UHFFFAOYSA-N ethyl 6-(bromomethyl)imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound S1C=CN2C(C(=O)OCC)=C(CBr)N=C21 RUNMRQIIEIASMK-UHFFFAOYSA-N 0.000 description 1
GINAWBFBOXKCOO-VAWYXSNFSA-N ethyl 6-[(e)-2-(2-cyclopentyloxy-3-methoxyphenyl)ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound N1=C2SC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC)=C1OC1CCCC1 GINAWBFBOXKCOO-VAWYXSNFSA-N 0.000 description 1
NIDWYFADVHFVRZ-ZHACJKMWSA-N ethyl 6-[(e)-2-[2-(2,2-dimethylpropoxy)-3-methoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound N1=C2SC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC)=C1OCC(C)(C)C NIDWYFADVHFVRZ-ZHACJKMWSA-N 0.000 description 1
OHTQYUMGBHYSKO-MDZDMXLPSA-N ethyl 6-[(e)-2-[2-(cyclobutylmethoxy)-3-(difluoromethoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound N1=C2SC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC(F)F)=C1OCC1CCC1 OHTQYUMGBHYSKO-MDZDMXLPSA-N 0.000 description 1
PQRTYPWETQYVPF-MDZDMXLPSA-N ethyl 6-[(e)-2-[2-(cyclopropylmethoxy)-3-methoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound N1=C2SC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC)=C1OCC1CC1 PQRTYPWETQYVPF-MDZDMXLPSA-N 0.000 description 1
XFSFCJIFGDLWBI-ZHACJKMWSA-N ethyl 6-[(e)-2-[2-cyclopentyloxy-3-(difluoromethoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound N1=C2SC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC(F)F)=C1OC1CCCC1 XFSFCJIFGDLWBI-ZHACJKMWSA-N 0.000 description 1
XJBMFKJBJRZLPM-MDZDMXLPSA-N ethyl 6-[(e)-2-[3-(difluoromethoxy)-2-(2,2-dimethylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound N1=C2SC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC(F)F)=C1OCC(C)(C)C XJBMFKJBJRZLPM-MDZDMXLPSA-N 0.000 description 1
GHKKQVLQIADTPJ-VOTSOKGWSA-N ethyl 6-[(e)-2-[3-(difluoromethoxy)-2-hydroxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound N1=C2SC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC(F)F)=C1O GHKKQVLQIADTPJ-VOTSOKGWSA-N 0.000 description 1
JVRKPDAENKLSPM-ZHACJKMWSA-N ethyl 6-[(e)-2-[3-(difluoromethoxy)-2-pentoxyphenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound CCCCCOC1=C(OC(F)F)C=CC=C1\C=C\C1=C(C(=O)OCC)N2C=CSC2=N1 JVRKPDAENKLSPM-ZHACJKMWSA-N 0.000 description 1
YXSAGWHFUWBUQJ-MDZDMXLPSA-N ethyl 6-[(e)-2-[3-methoxy-2-(2-methylpropoxy)phenyl]ethenyl]imidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound N1=C2SC=CN2C(C(=O)OCC)=C1\C=C\C1=CC=CC(OC)=C1OCC(C)C YXSAGWHFUWBUQJ-MDZDMXLPSA-N 0.000 description 1
NSUFDDBQLKSSIN-UHFFFAOYSA-N ethyl 6-methylimidazo[2,1-b][1,3]thiazole-5-carboxylate Chemical compound S1C=CN2C(C(=O)OCC)=C(C)N=C21 NSUFDDBQLKSSIN-UHFFFAOYSA-N 0.000 description 1
VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
230000004907 flux Effects 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
125000002541 furyl group Chemical group 0.000 description 1
150000002357 guanidines Chemical class 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
150000002430 hydrocarbons Chemical group 0.000 description 1
125000001183 hydrocarbyl group Chemical group 0.000 description 1
ZTUJDPKOHPKRMO-UHFFFAOYSA-N hydron;2,2,2-trifluoroethanamine;chloride Chemical compound Cl.NCC(F)(F)F ZTUJDPKOHPKRMO-UHFFFAOYSA-N 0.000 description 1
150000002440 hydroxy compounds Chemical class 0.000 description 1
229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
UTCSSFWDNNEEBH-UHFFFAOYSA-N imidazo[1,2-a]pyridine Chemical group C1=CC=CC2=NC=CN21 UTCSSFWDNNEEBH-UHFFFAOYSA-N 0.000 description 1
DOGXPDFZEQXZDS-UHFFFAOYSA-N imidazo[1,2-a]pyridine-3-carboxylic acid Chemical compound C1=CC=CN2C(C(=O)O)=CN=C21 DOGXPDFZEQXZDS-UHFFFAOYSA-N 0.000 description 1
ZGIABSKPSCMXFD-UHFFFAOYSA-N imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound S1C=CN2C(C(=O)O)=CN=C21 ZGIABSKPSCMXFD-UHFFFAOYSA-N 0.000 description 1
229910052738 indium Inorganic materials 0.000 description 1
125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
239000003999 initiator Substances 0.000 description 1
229940102223 injectable solution Drugs 0.000 description 1
229940102213 injectable suspension Drugs 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007915 intraurethral administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
239000011630 iodine Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 description 1
125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
125000005956 isoquinolyl group Chemical group 0.000 description 1
125000001786 isothiazolyl group Chemical group 0.000 description 1
125000003965 isoxazolidinyl group Chemical group 0.000 description 1
125000000842 isoxazolyl group Chemical group 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
239000008101 lactose Substances 0.000 description 1
150000007517 lewis acids Chemical class 0.000 description 1
239000003446 ligand Substances 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
239000011344 liquid material Substances 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
239000006166 lysate Substances 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
230000028161 membrane depolarization Effects 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
125000002757 morpholinyl group Chemical group 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
CRSOQBOWXPBRES-UHFFFAOYSA-N neopentane Chemical compound CC(C)(C)C CRSOQBOWXPBRES-UHFFFAOYSA-N 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
125000005060 octahydroindolyl group Chemical group N1(CCC2CCCCC12)* 0.000 description 1
125000005061 octahydroisoindolyl group Chemical group C1(NCC2CCCCC12)* 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
125000001715 oxadiazolyl group Chemical group 0.000 description 1
150000002916 oxazoles Chemical class 0.000 description 1
125000000160 oxazolidinyl group Chemical group 0.000 description 1
125000005968 oxazolinyl group Chemical group 0.000 description 1
125000002971 oxazolyl group Chemical group 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
125000004043 oxo group Chemical group O=* 0.000 description 1
125000005476 oxopyrrolidinyl group Chemical group 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000008024 pharmaceutical diluent Substances 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
125000003386 piperidinyl group Chemical group 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
125000003367 polycyclic group Chemical group 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 1
125000003373 pyrazinyl group Chemical group 0.000 description 1
LETVJWLLIMJADE-UHFFFAOYSA-N pyridazin-3-amine Chemical compound NC1=CC=CN=N1 LETVJWLLIMJADE-UHFFFAOYSA-N 0.000 description 1
125000002098 pyridazinyl group Chemical group 0.000 description 1
LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 description 1
OYRRZWATULMEPF-UHFFFAOYSA-N pyrimidin-4-amine Chemical compound NC1=CC=NC=N1 OYRRZWATULMEPF-UHFFFAOYSA-N 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
125000000719 pyrrolidinyl group Chemical group 0.000 description 1
125000000168 pyrrolyl group Chemical group 0.000 description 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
125000005493 quinolyl group Chemical group 0.000 description 1
125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
108700021113 rat TRPV3 Proteins 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
206010039083 rhinitis Diseases 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
239000012056 semi-solid material Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
210000004927 skin cell Anatomy 0.000 description 1
QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
229910001415 sodium ion Inorganic materials 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
239000011343 solid material Substances 0.000 description 1
239000012265 solid product Substances 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
241000894007 species Species 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
210000003594 spinal ganglia Anatomy 0.000 description 1
125000003003 spiro group Chemical group 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
230000000707 stereoselective effect Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
125000005017 substituted alkenyl group Chemical group 0.000 description 1
125000000547 substituted alkyl group Chemical group 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
125000004434 sulfur atom Chemical group 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
238000011287 therapeutic dose Methods 0.000 description 1
150000004867 thiadiazoles Chemical class 0.000 description 1
125000006090 thiamorpholinyl sulfone group Chemical group 0.000 description 1
125000006089 thiamorpholinyl sulfoxide group Chemical group 0.000 description 1
150000003557 thiazoles Chemical class 0.000 description 1
125000001984 thiazolidinyl group Chemical group 0.000 description 1
125000002769 thiazolinyl group Chemical group 0.000 description 1
125000000335 thiazolyl group Chemical group 0.000 description 1
125000001544 thienyl group Chemical group 0.000 description 1
125000004568 thiomorpholinyl group Chemical group 0.000 description 1
229940100615 topical ointment Drugs 0.000 description 1
WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
125000004306 triazinyl group Chemical group 0.000 description 1
125000001425 triazolyl group Chemical group 0.000 description 1
210000000427 trigeminal ganglion Anatomy 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
238000010626 work up procedure Methods 0.000 description 1

JP2011540235A 2008-12-15 2009-12-15 Ｔｒｐｖ３モジュレーターとしての縮合イミダゾールカルボキサミド Pending JP2012512151A (ja)